68
Views
0
CrossRef citations to date
0
Altmetric
Short Communications

Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection

, , , &
Pages 319-323 | Received 05 Mar 2012, Accepted 30 Apr 2012, Published online: 11 Jun 2012

References

  • Fabri M, Stenger S, Shin DM, . Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011; 3: 1–10.
  • Hansdottir S, Monick MM, Hinde SL, . Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008; 181: 7090–7099.
  • Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169: 384–390.
  • Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37: 113–119.
  • Stiles GW, Davis CL. Coccidioidal granuloma (coccidioidomycosis). J Amer Med Assoc 1942; 119: 765–769.
  • Bodnar LM, Simhan HN, Powers RW, . High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007; 137: 447–452.
  • De Pauw B, Walsh TJ, Donnelly JP, . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911–1930.
  • Thompson GR 3rd. Pulmonary coccidioidomycosis. Semin Respir Crit Care Med 2011; 32: 754–763.
  • Rosenstein NE, Emery KW, Werner SB, . Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995–1996. Clin Infect Dis 2001; 32: 708–715.
  • Bellamy R. Interferon-gamma and host susceptibility to tuberculosis. Am J Respir Crit Care Med 2003; 167: 946–947.
  • Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun 2003; 4: 4–11.
  • Louie L, Ng S, Hajjeh R, . Influence of host genetics on the severity of coccidioidomycosis. Emerg Infect Dis 1999; 5: 672–680.
  • Davies PD, Brown RC, Church HA, Woodhead JS. The effect of anti-tuberculosis chemotherapy on vitamin D and calcium metabolism. Tubercle 1987; 68: 261–266.
  • Heidari A DJ, Jahangiri N, Ghafarizadeh N, Petersen G. Evaluation of vitamin D levels in patients with coccidioidomycosis, a case control study. In: Programs and Abstracts of the 49th Annual Infectious Diseases Society of America (IDSA) Meeting. Boston, MA: 2011: Poster # 947.
  • Rockett KA, Brookes R, Udalova I, . 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66: 5314–5321.
  • Coussens A, Timms PM, Boucher BJ, . 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2009; 127: 539–548.
  • Segal GP, Lehrer RI, Selsted ME. In vitro effect of phagocyte cationic peptides on Coccidioides immitis. J Infect Dis 1985; 151: 890–894.
  • Martineau AR, Wilkinson KA, Newton SM, . IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007; 178: 7190–7198.
  • Martineau AR, Timms PM, Bothamley GH, . High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242–250.
  • Cox RA. Immunosuppression by cell wall antigens of Coccidioides immitis. Rev Infect Dis 1988; 10 (Suppl. 2): S415–418.
  • Thomas MK, Lloyd-Jones DM, Thadhani RI, . Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777–783.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.